Evidence map›Paper›PMID 35919256›Full record

ArticleMedecine tropicale et sante internationale2022

[Clinical aspects of Neurofibromatosis type 1 seen in the Department of Dermatology at University Hospital Antananarivo, Madagascar].

Fandresena Arilala Sendrasoa, Aurélie Rasoarisata, Lala Soavina Ramarozatovo, Fahafahantsoa Rapelanoro Rabenja

Open access · greenAbstract read
In one paragraph

Article in Medecine tropicale et sante internationale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fandresena Arilala SendrasoaDépartement de dermatologie, Centre hospitalier universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar.
Aurélie RasoarisataDépartement de dermatologie, Centre hospitalier universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar.
Lala Soavina RamarozatovoDépartement de dermatologie, Centre hospitalier universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar.
Fahafahantsoa Rapelanoro RabenjaDépartement de dermatologie, Centre hospitalier universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar.
Association Vahatra · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Neurofibromatosis 1 (NF1) is an inherited disease, in an autosomal dominant manner, with complex multi-system involvements. Prevalence varies from one country to another. However, little is known about neurofibromatosis in African countries, particularly in Madagascar. Methodology: A descriptive retrospective study from 2014 to 2019 was conducted at the service of dermatology at University Hospital Joseph Raseta Befelatanana in Antananarivo, including all patients with neurofibromatosis according to National Institutes of Health Consensus Conference criteria for whom genealogical investigation could be made. Results: Among 32 cases of NF1 seen during 6 years, 28 cases were included with a sex ratio M/F of 0.87. The mean age was 24 years ranging from 11 to 54 years. Seventeen patients presented sporadic forms. All patients had "café au lait" spots and cutaneous neurofibromatosis. Three cases presented plexiform neurofibromas which cause significant cosmetic and functional problems by their size and their displayed topography. Fifteen patients had Lisch nodules but no case of optic glioma was identified. Neurological symptoms such as learning difficulties, epilepsy and headache were frequent in our case series. However, access to medical imaging was very limited. Scoliosis was the most common orthopedic complication. Conclusion: The clinical manifestations of NF1 are extremely variable. Although the possibility of systemic complications seems to be low, patients must be followed up.

Indexed as

Cafe-au-Lait SpotsNeurofibromatosis 1AdultDermatologyHospitalsHumansMadagascarRetrospective StudiesYoung AdultAntananarivoIndian OceanMadagascarNeurofibromatosis type 1Sporadic forms

Identifiers

PMID35919256
PMCPMC9326780
OpenAlexW4289786411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.